Back to search

Article

Immunophenotyping reveals longitudinal changes in circulating immune cells during radium-223 therapy in patients with metastatic castration-resistant prostate cancer

2020-11-12

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Purpose</h4> Radium-223 improves overall survival (OS) in men with bone metastatic castration-resistant prostate cancer (mCRPC). While the exact mechanism behind this survival benefit remains unclear, radium-induced immunological mechanisms might contribute to the OS advantage. We performed a comprehensive evaluation of the immunological changes in mCRPC patients by phenotyping the peripheral...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5487d25b-814a-5b15-8e2f-40df44bb2a4a
DOI
10.1101/2020.11.11.20229831
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Immunophenotyping reveals longitudinal changes in circulating immune cells during radium-223 therapy in patients with metastatic castration-resistant prostate cancerDOI 10.1101/2020.11.11.20229831
Select a neighboring publication to make it the new centre.